Sacubitril-Valsartan for the Treatment of Heart Failure : Effectiveness and Value
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:176 |
|---|---|
| Enthalten in: |
JAMA internal medicine - 176(2016), 2 vom: 27. Feb., Seite 249-50 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ollendorf, Daniel A [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 27.06.2016 Date Revised 03.12.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1001/jamainternmed.2015.7661 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM256050457 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM256050457 | ||
| 003 | DE-627 | ||
| 005 | 20231224175809.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jamainternmed.2015.7661 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0853.xml |
| 035 | |a (DE-627)NLM256050457 | ||
| 035 | |a (NLM)26720832 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ollendorf, Daniel A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sacubitril-Valsartan for the Treatment of Heart Failure |b Effectiveness and Value |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.06.2016 | ||
| 500 | |a Date Revised 03.12.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Aminobutyrates |2 NLM | |
| 650 | 7 | |a Angiotensin Receptor Antagonists |2 NLM | |
| 650 | 7 | |a Biphenyl Compounds |2 NLM | |
| 650 | 7 | |a Drug Combinations |2 NLM | |
| 650 | 7 | |a Tetrazoles |2 NLM | |
| 650 | 7 | |a Valsartan |2 NLM | |
| 650 | 7 | |a 80M03YXJ7I |2 NLM | |
| 650 | 7 | |a sacubitril and valsartan sodium hydrate drug combination |2 NLM | |
| 650 | 7 | |a WB8FT61183 |2 NLM | |
| 700 | 1 | |a Sandhu, Alexander T |e verfasserin |4 aut | |
| 700 | 1 | |a Pearson, Steven D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA internal medicine |d 2013 |g 176(2016), 2 vom: 27. Feb., Seite 249-50 |w (DE-627)NLM220635021 |x 2168-6114 |7 nnns |
| 773 | 1 | 8 | |g volume:176 |g year:2016 |g number:2 |g day:27 |g month:02 |g pages:249-50 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1001/jamainternmed.2015.7661 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 176 |j 2016 |e 2 |b 27 |c 02 |h 249-50 | ||